Your browser doesn't support javascript.
loading
Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair.
Robb, Ryan; Yang, Linlin; Shen, Changxian; Wolfe, Adam R; Webb, Amy; Zhang, Xiaoli; Vedaie, Marall; Saji, Motoyasu; Jhiang, Sissy; Ringel, Matthew D; Williams, Terence M.
Afiliación
  • Robb R; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Yang L; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Shen C; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Wolfe AR; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Webb A; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Zhang X; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Vedaie M; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Saji M; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Jhiang S; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Ringel MD; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio.
  • Williams TM; Arthur G. James Comprehensive Cancer Center and Richard J. Solove Research Institute, The Ohio State University Medical Center, Columbus, Ohio. terence.williams@osumc.edu.
Clin Cancer Res ; 25(15): 4749-4760, 2019 08 01.
Article en En | MEDLINE | ID: mdl-31097454
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Tolerancia a Radiación / Neoplasias de la Tiroides / Proteínas Proto-Oncogénicas B-raf / Roturas del ADN de Doble Cadena / Vemurafenib Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Tolerancia a Radiación / Neoplasias de la Tiroides / Proteínas Proto-Oncogénicas B-raf / Roturas del ADN de Doble Cadena / Vemurafenib Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article